EDGAR Filing Documents for 0001564590-22-027331

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-22-027331

Filing Date

2022-08-02

Accepted

2022-08-02 07:20:44

Documents

Period of Report

2022-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	sage-10q_20220630.htm iXBRL	10-Q	3440749
2	EX-10.1	sage-ex101_207.htm	EX-10.1	32449
3	EX-10.2	sage-ex102_208.htm	EX-10.2	39122
4	EX-31.1	sage-ex311_8.htm	EX-31.1	9330
5	EX-31.2	sage-ex312_9.htm	EX-31.2	9281
6	EX-32.1	sage-ex321_10.htm	EX-32.1	8642
7	GRAPHIC	g2wdyohjig4f000001.jpg	GRAPHIC	157484
	Complete submission text file	0001564590-22-027331.txt		11476564

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	sage-20220630.xsd	EX-101.SCH	49831
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	sage-20220630_cal.xml	EX-101.CAL	44280
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	sage-20220630_def.xml	EX-101.DEF	188592
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	sage-20220630_lab.xml	EX-101.LAB	390869
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	sage-20220630_pre.xml	EX-101.PRE	309015
52	EXTRACTED XBRL INSTANCE DOCUMENT	sage-10q_20220630_htm.xml	XML	2458169

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142

Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380

Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)